Stock Earnings

Question 1

What are Dianthus Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Dianthus Therapeutics Inc has a total asset of $374, Net loss of $-84

Question 2

What are the key financial ratios for DNTH?

Accepted Answer

Dianthus Therapeutics Inc's Current ratio is 17.8, has a Net margin is -1,400, sales per share of $0.18.

Question 3

How is Dianthus Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Dianthus Therapeutics Inc largest revenue segment is Complement Therapeutics, at a revenue of 6,235,000 in the most earnings release.For geography, United States is the primary market for Dianthus Therapeutics Inc, at a revenue of 6,235,000.

Question 4

Is Dianthus Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Dianthus Therapeutics Inc has a net loss of $-84

Question 5

Does Dianthus Therapeutics Inc have any liabilities?

Accepted Answer

yes, Dianthus Therapeutics Inc has liability of 21

Question 6

How many outstanding shares for Dianthus Therapeutics Inc?

Accepted Answer

Dianthus Therapeutics Inc has a total outstanding shares of 31.11

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	3	6	2	0	0	0
Revenue Growth (YoY)	-40%	200%	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	31	25	18	25	27	28
Research & Development	112	83	32	55	46	50
Operating Expenses	143	108	51	80	74	78
Other Non Operating Income (Expenses)	0	0	0	--	--	--
Pretax Income	-126	-84	-43	-76	-71	-74
Income Tax Expense	--	--	--	--	--	--
Net Income	-126	-84	-43	-76	-71	-74
Net Income Growth	88%	95%	-43%	7%	-4%	-3%
Shares Outstanding (Diluted)	37.79	33.31	5.15	3.71	3.43	2.75
Shares Change (YoY)	10%	546%	39%	8%	25%	19%
EPS (Diluted)	-3.34	-2.55	-8.45	-20.61	-20.74	-27.25
EPS Growth	71%	-70%	-59%	-1%	-24%	-18%
Free Cash Flow	-109	-78	-36	-67	-60	-64
Free Cash Flow Per Share	-2.88	-2.34	-6.98	-18.05	-17.49	-23.27
Gross Margin	--	--	--	--	--	--
Operating Margin	-4,666.66%	-1,683.33%	-2,400%	0%	0%	0%
Profit Margin	-4,200%	-1,400%	-2,150%	0%	0%	0%
Free Cash Flow Margin	-3,633.33%	-1,300%	-1,800%	0%	0%	0%
EBITDA	-140	-101	-48	-79	-72	-77
EBITDA Margin	-4,666.66%	-1,683.33%	-2,400%	0%	0%	0%
D&A For EBITDA	0	0	0	1	2	1
EBIT	-140	-101	-48	-80	-74	-78
EBIT Margin	-4,666.66%	-1,683.33%	-2,400%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Dianthus Therapeutics Inc (DNTH) Price

DNTH Stock Price Chart

DNTH Income

Follow-Up Questions